HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernard Escudier Selected Research

Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)

2/2022Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.
12/2021Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bernard Escudier Research Topics

Disease

246Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 07/2003
108Neoplasms (Cancer)
04/2024 - 03/2002
36Kidney Neoplasms (Kidney Cancer)
10/2023 - 04/2002
20Fatigue
01/2020 - 01/2007
17Neoplasm Metastasis (Metastasis)
10/2023 - 01/2006
16Disease Progression
10/2022 - 01/2007
13Hypertension (High Blood Pressure)
01/2022 - 01/2007
11Melanoma (Melanoma, Malignant)
01/2020 - 03/2002
8Hypoxia (Hypoxemia)
10/2016 - 01/2007
7Prostatic Neoplasms (Prostate Cancer)
05/2022 - 03/2003
6Diarrhea
10/2018 - 01/2007
6Exanthema (Rash)
10/2016 - 01/2007
6Carcinoma (Carcinomatosis)
11/2015 - 05/2007
4Stomatitis
01/2020 - 08/2008
4Proteinuria
12/2015 - 01/2011
3Brain Neoplasms (Brain Tumor)
01/2023 - 02/2014
3Pain (Aches)
11/2018 - 03/2003
3Dyspnea (Shortness of Breath)
10/2018 - 06/2007
3Nausea
10/2018 - 03/2009
3Hyperglycemia
10/2016 - 03/2014
3Pneumonia (Pneumonitis)
03/2014 - 08/2008
3Clear-cell metastatic renal cell carcinoma
03/2014 - 12/2012
3Asthenia
03/2013 - 12/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 03/2017
2Inflammation (Inflammations)
02/2024 - 03/2014
2Pruritus (Itching)
01/2020 - 02/2009
2Body Weight (Weight, Body)
04/2018 - 11/2015
2Stomach Neoplasms (Stomach Cancer)
10/2017 - 10/2014
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017 - 03/2011
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017 - 10/2010
2Anemia
12/2016 - 11/2015
2Hypercholesterolemia
10/2016 - 03/2014
2Posterior Leukoencephalopathy Syndrome
10/2016 - 02/2014
2Edema (Dropsy)
12/2015 - 04/2012
2Renal Insufficiency (Renal Failure)
09/2013 - 05/2007
2Hand-Foot Syndrome
05/2013 - 07/2008
2Cough
04/2012 - 06/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012 - 08/2009
2Keratoacanthoma
01/2012 - 08/2009

Drug/Important Bio-Agent (IBA)

63Sunitinib (Sutent)FDA Link
02/2022 - 01/2008
45Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 06/2004
39Sorafenib (BAY 43-9006)FDA Link
01/2023 - 05/2006
34NivolumabIBA
02/2024 - 11/2015
34EverolimusFDA Link
01/2022 - 08/2008
30Bevacizumab (Avastin)FDA Link
02/2022 - 12/2007
26Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2006
23Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2024 - 08/2005
21Immune Checkpoint InhibitorsIBA
04/2024 - 11/2015
21cabozantinibIBA
11/2023 - 11/2015
20Biomarkers (Surrogate Marker)IBA
04/2024 - 06/2004
16Axitinib (AG 013736)IBA
01/2023 - 01/2011
15IpilimumabIBA
10/2023 - 04/2018
14CytokinesIBA
02/2024 - 03/2002
12Interleukin-2 (IL2)IBA
12/2017 - 03/2002
10TOR Serine-Threonine KinasesIBA
01/2019 - 08/2008
8atezolizumabIBA
02/2022 - 01/2018
8Peptides (Polypeptides)IBA
01/2020 - 02/2004
8Interferon-alpha (Interferon Alfa)IBA
03/2017 - 01/2006
8InterferonsIBA
08/2016 - 04/2002
8temsirolimusFDA Link
10/2015 - 09/2008
7pazopanibFDA Link
12/2021 - 01/2011
7Proteins (Proteins, Gene)FDA Link
10/2016 - 10/2002
6Angiogenesis InhibitorsIBA
01/2023 - 12/2005
5tivozanibIBA
01/2024 - 08/2014
5LigandsIBA
02/2022 - 02/2005
5Phosphotransferases (Kinase)IBA
01/2022 - 07/2005
5B7-H1 AntigenIBA
01/2022 - 10/2016
5AntigensIBA
01/2020 - 03/2002
5Monoclonal AntibodiesIBA
08/2017 - 06/2014
4MTOR InhibitorsIBA
10/2015 - 08/2010
4Interferon alpha-2 (Roferon-A)FDA Link
05/2010 - 12/2007
3Interleukin-6 (Interleukin 6)IBA
02/2024 - 06/2004
3Messenger RNA (mRNA)IBA
06/2020 - 03/2002
34- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
06/2014 - 03/2013
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2008 - 10/2002
3HLA-A2 Antigen (HLA A2 Antigen)IBA
03/2005 - 02/2004
2Proton Pump InhibitorsIBA
10/2022 - 01/2021
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2022 - 12/2021
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2018
2AmylasesFDA Link
10/2019 - 12/2015
2CrizotinibIBA
11/2018 - 12/2017
2Tyrosine (L-Tyrosine)FDA Link
10/2018 - 10/2002
2Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 10/2010
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 05/2007
2InterleukinsIBA
08/2016 - 06/2007
2AndrogensIBA
01/2016 - 09/2015
2Epidermal Growth Factor (EGF)IBA
07/2014 - 12/2012
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
06/2014 - 03/2013
2Carbonic Anhydrase IXIBA
12/2012 - 10/2010
2GemcitabineFDA Link
05/2012 - 05/2007
2PlatinumIBA
05/2012 - 05/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2012 - 11/2009

Therapy/Procedure

124Therapeutics
04/2024 - 03/2002
27Nephrectomy
01/2023 - 12/2005
13Immunotherapy
04/2024 - 03/2002
11Drug Therapy (Chemotherapy)
01/2017 - 07/2003
5Radiotherapy
11/2018 - 04/2014
5Castration
01/2016 - 05/2009
3Injections
10/2009 - 03/2002
2Molecular Targeted Therapy
06/2016 - 02/2014